Arkolith/Insider Trading/LCTX/Form 4

Samuel George A. III

General Counsel and SecretaryLineage Cell Therapeutics, Inc. (LCTX) · full profile →Form 4 · filed Feb 13, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 11, 2026Option exercise(M)6K——34K
Feb 11, 2026Tax withholding(F)3K$1.80$5K31K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 11, 2026Option exercise(M)6K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-052020) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML